Dr. Epting is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Ann & Robert H. Lurie Children’s Hospital of Chicago, Box 73
225 East Chicago Ave
Chicago, IL 60611Phone+1 312-227-4916Fax+1 312-503-1181
Summary
- Conrad L. Epting, MD is an Associate Professor of Pediatrics and Pathology, Northwestern University, and an attending Pediatric and Cardiac ICU physician at the Ann & Robert H. Lurie CHildren’s Hospital of Chicago. Dr. Epting directs the Heart Center Cardiac Biorepository, the INVEST program (INnovation in Ventricular failure, Stem cells, and Translational research), and the Fontan Futures initiative.. Dr. Epting serves as the Associate Program Director for Research in the Pediatric Critical Care Fellowship.
While an undergraduate at the University of Iowa, Dr. Epting studied neurogenesis and cell signaling with Dr. Steven Green as he completed a degree in the Biological Sciences. He completed his medical training at Johns Hopkins School of Medicine, did his Pediatric residency at the University of Colorado and Denver Children’s Hospital, and, pursued fellowship in Pediatric Critical Care at the University of California, San Francisco and Children’s Hospital of Oakland. At UCSF, he was a fellow at the Cardiovascular research institution from 2000-2004, and went on to complete postdoctoral training in skeletal myogenesis with Dr. Harold Bernstein.
He transitioned on the faculty at UCSF between 2004-2007, and was subsequently recruited to Northwestern University. His independent academic work between 2007-2012 centered around myocardial targeting by pathogens, specifically Trypanosoma cruzi, in collaboration with Dr. David Engman, and in 2013 his laboratory shifted to the study of human pediatric heart disease, specifically cardiac stem cells and the regulation of heart failure. Presently he studies the epigenetic modifications regulating stem cell phenotype following exposure to end-stage heart failure.
He has been the recipient of numerous awards and has received funding from the March of Dimes, the NICHD, the Children’s Heart and Mend a Heart Foundations, the Mathews Center for Cellular Therapy, and from multiple other intramural sources.
Education & Training
- University of California San Francisco School of MedicinePost-Doctoral Fellowship, 2002 - 2005
- University of California (San Francisco)Fellowship, Pediatric Critical Care Medicine, 2000 - 2004
- University of California San Francisco School of MedicinePost-Doctoral Fellowship, 2000 - 2004
- University of ColoradoResidency, Pediatrics, 1997 - 2000
- Johns Hopkins University School of MedicineClass of 1997
Certifications & Licensure
- IL State Medical License 2007 - 2026
- CA State Medical License 2001 - 2024
- CO State Medical License 1999 - 2003
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Critical Care Medicine
Publications & Presentations
PubMed
- 103 citationsA timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cellsPeter W. Mesner, Conrad L. Epting, Joseph L. Hegarty, Steven H. Green
The Journal of Neuroscience. 1995-11-01 - 68 citationsNegligible-Cost and Weekend-Free Chemically Defined Human iPSC CultureHui Hsuan Kuo, Xiaozhi Gao, Jean Marc DeKeyser, K. Ashley Fetterman, Emily Pinheiro
Stem Cell Reports. 2020-02-11 - 99 citationsSirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2Xiaoyan Yang, Seong Hoon Park, Hsiang-Chun Chang, Jason S. Shapiro, Athanassios Vassilopoulos
The Journal of Clinical Investigation. 2017-04-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: